Last reviewed · How we verify
Valchlor 0.016 % Topical Gel — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Valchlor 0.016 % Topical Gel (Valchlor 0.016 % Topical Gel) — Rochester Skin Lymphoma Medical Group, PLLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Valchlor 0.016 % Topical Gel TARGET | Valchlor 0.016 % Topical Gel | Rochester Skin Lymphoma Medical Group, PLLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Valchlor 0.016 % Topical Gel CI watch — RSS
- Valchlor 0.016 % Topical Gel CI watch — Atom
- Valchlor 0.016 % Topical Gel CI watch — JSON
- Valchlor 0.016 % Topical Gel alone — RSS
Cite this brief
Drug Landscape (2026). Valchlor 0.016 % Topical Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/valchlor-0-016-topical-gel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab